CAS 295350-45-7

Ozarelix

Description:

Ozarelix is a synthetic peptide that functions as a gonadotropin-releasing hormone (GnRH) antagonist. It is primarily used in the context of treating hormone-sensitive conditions, such as prostate cancer, by inhibiting the release of gonadotropins from the pituitary gland, thereby reducing testosterone levels. The chemical structure of Ozarelix includes a sequence of amino acids that confer its biological activity, and it is characterized by its ability to bind to GnRH receptors with high affinity, blocking the action of natural GnRH. This mechanism of action leads to a decrease in the production of sex hormones, which is beneficial in managing certain hormone-dependent diseases. Ozarelix is typically administered via injection and has been studied for its pharmacokinetics, safety, and efficacy in clinical settings. As with many peptide-based drugs, its stability and solubility are important factors influencing its formulation and delivery. Overall, Ozarelix represents a targeted therapeutic approach in the management of specific endocrine-related conditions.

Formula: C₇₂H₉₆ClN₁₇O₁₄

Synonyms:

• D-63153
• Ozarelix Acetate
• AC-D-2-NAL-D-4-CPA-D-3-PAL-SER-N-ME-TYR-D-HCI-NLE-ARG-PRO-D-ALA-NH2
• Ozarrelix
• Ac-D-2-Nal-D-4-Cpa-D-3-Pal-Ser-N-Me-Tyr-D-Hci-Nle-Arg-Pro-D-Ala-NH2 acetate salt
• N-Acetyl-3-(2-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanyl-L-seryl-N-methyl-L-tyrosyl-N6-(aminocarbonyl)-D-lysyl-L-norleucyl-L-arginyl-L-prolyl-D-alaninamide
• Ozarelix
• D 63153
• D-Alaninamide, N-acetyl-3-(2-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanyl-L-seryl-N-methyl-L-tyrosyl-N6-(aminocarbonyl)-D-lysyl-L-norleucyl-L-arginyl-L-prolyl-

D-Alaninamide, N-acetyl-3-(2-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanyl-L-seryl-N-methyl-L-tyrosyl-N6-(aminocarbonyl)-D-lysyl-L-norleucyl-L-arginyl-L-prolyl-

CAS: 295350-45-7

Formula: C₇₂H₉₆ClN₁₇O₁₄

Molecular weight: 1459.0911

Ref: IN-DA002YOD

Ozarelix

CAS: 295350-45-7

Ozarelix: a GnRH antagonist that induces apoptosis in advanced prostate cancer, modulates death receptors, and reduces sex hormones.

Formula: C₇₂H₉₆ClN₁₇O₁₄

Color and Shape: Solid

Molecular weight: 1459.09

Ref: TM-T69492

Ozarelix acetate salt

CAS: 295350-45-7

Ozarelix acetate salt is a synthetic androgen that has been shown to have pharmacological activity in the treatment of prostate cancer. It binds to albumin, which is found in high concentrations in the prostate, and is then released slowly over time. In rat studies, it has been shown to improve symptoms of depression by binding to serotonin receptors. This drug also binds with fatty acids in blood plasma and can be used as a biomarker for the presence of cancer. Ozarelix acetate salt has not been studied extensively in humans, but has shown promising results when used for the treatment of diabetic neuropathy and for cancer prevention.

Formula: C₇₂H₉₆ClN₁₇O₁₄

Purity: Min. 95%

Molecular weight: 1,459.09 g/mol

Ref: 3D-FO110080